Literature DB >> 6319570

Entry of mouse hepatitis virus 3 into cells.

K Krzystyniak, J M Dupuy.   

Abstract

The involvement of lysosomes in infection by mouse hepatitis virus 3 (MHV3) was studied. L cells were infected with MHV3 in the presence of NH4Cl or chloroquine, weak bases which increase the intralysosomal pH and impair lysosomal functions. NH4Cl significantly inhibited virus-induced cytopathic effects and MHV3 replication, but did not prevent the attachment of 3H-labelled virus. No inhibition of MHV3 replication by NH4Cl and chloroquine was observed when lysosomotropic agents were added later than 3 h post-infection, suggesting the direct involvement of lysosomes in release of the viral genome into cytoplasm. These results, together with the lack of antibody-mediated immune lysis of MHV3-infected cells, suggest that MHV3 entered cells by an endocytic pathway (viropexis) followed by internalization into cellular lysosomes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319570     DOI: 10.1099/0022-1317-65-1-227

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication.

Authors:  Y van der Meer; E J Snijder; J C Dobbe; S Schleich; M R Denison; W J Spaan; J K Locker
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry.

Authors:  Patricia Eifart; Kai Ludwig; Christoph Böttcher; Cornelis A M de Haan; Peter J M Rottier; Thomas Korte; Andreas Herrmann
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

4.  The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells.

Authors:  D W Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

5.  Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.

Authors:  Zhaozhu Qiu; Susan T Hingley; Graham Simmons; Christopher Yu; Jayasri Das Sarma; Paul Bates; Susan R Weiss
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Authors:  Adriaan H de Wilde; Dirk Jochmans; Clara C Posthuma; Jessika C Zevenhoven-Dobbe; Stefan van Nieuwkoop; Theo M Bestebroer; Bernadette G van den Hoogen; Johan Neyts; Eric J Snijder
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

7.  Initial events in bovine coronavirus infection: analysis through immunogold probes and lysosomotropic inhibitors.

Authors:  H R Payne; J Storz; W G Henk
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment.

Authors:  G H Hansen; B Delmas; L Besnardeau; L K Vogel; H Laude; H Sjöström; O Norén
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 10.  A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.

Authors:  Steve P H Alexander; Jane F Armstrong; Anthony P Davenport; Jamie A Davies; Elena Faccenda; Simon D Harding; Francesca Levi-Schaffer; Janet J Maguire; Adam J Pawson; Christopher Southan; Michael Spedding
Journal:  Br J Pharmacol       Date:  2020-07-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.